Ekf Diagnostics Share Discussion Threads

[andrewbaker] 17/12/2014 11:00

The price fall is overdone. I have an alert in place to buy more when the northwards trend restarts. This has a forward PEG of 0.2 for a year's time. If they don't get all the increased sales predicted, it will still be a good buy at today's price plus a little (enough to trigger my buy alert).

[totaleclipse] 17/12/2014 10:21

Well I should have heeded my own advice perhaps- to sell and buy back but I didn't. Currency fluctuations are such an unpredictable quantity but underlying performance is good. I'm going to keep the faith with this one for now. A little more clarity on the performance of the recent acquisitions especially Selah would be helpful.

[totaleclipse] 16/12/2014 09:10

Looking in the 2013 results it was declared that with the Rouble at around 50/55 to the £ revenue from Russia was about 12% of the total declared (around £4million). With the Rouble now at well over 100 to the £ these revenues are going to be hit quite hard- more than was reported at the half way stage. I reckon about £2 million knocked off revenues.

[totaleclipse] 01/12/2014 20:44

From something that was said at 6month trading updates I think EKF are quite exposed to trade in Russia. If so the falling value of the rouble isn't going to improve the year end numbers

[croasdalelfc] 19/11/2014 21:30

Interesting agenda at distributor meeting:http://www.ekfdiagnostics.com/system/resources/interfaces/ContentDocument.ashx?id=254

[croasdalelfc] 19/11/2014 21:29

2015 catalogue with all new products integrated:http://online.fliphtml5.com/pwsc/xzzb/xzzb.pdf

[eclectictrends] 11/11/2014 23:03

Interesting, the guy that ran Inverness Medical, which become Alere, and previously bought BBI International, the last Evans/Baines stockmarket vehicle

[rambutan2] 11/11/2014 17:15

Interesting shareholder has popped over 3%...

[cisk] 08/10/2014 15:48

suspect we'll see an RNS soon re: the awarding of either the Mexican or South African contracts... news leaking out maybe?

[totaleclipse] 08/10/2014 14:28

Well, Andrew, the price is flying a bit. And lots of trades which is good (I think). I wonder if anything is going on?

[andrewbaker] 08/10/2014 13:33

Despite a possible overhang of shares waiting to be sold, watch the price fly soon. Director buying + a great cutting edge business + impressive trading figures + equally impressive (realistic, IMHO) projections = big gains ahead.

I'm long, and will buy more when my buy alert is triggered again, which is coming soon.

[totaleclipse] 18/9/2014 15:07

Cisk- thank you so much for the summary- much appreciated. Still as I write this another huge chunk of shares traded and the price off another 5%. I still think the big issue for EFK is the number of shares held by acquirees in exchange for their businesses. These guys are going to want to get their cash out at some point, if they haven't already, so whenever the price looks to improve another tranche of chips will be cashed and the price will stay low. I suppose this is a share to stop checking to avoid daily disappointment but I wonder how long they need to build the dream of a "world class molecular diagnostics company" Some of us have been in a long time and are still waiting.

[silverfern] 15/9/2014 12:43

Total payment for selah (inc earnout) = $70m/£42m Total sales for Selha 2013 = $1m; placing price was 35p. I would imagine all this has damaged the reputation of the key players in this business. It cannot be how they saw EKF developing when they launched it. What would ALere pay for this now?

[stupidboypike] 15/9/2014 11:52

Someone is voting with their wallets, that's about 8.5m shares just sold!
Can see long term value here but glad I'm only a watcher at the moment.
(apart from a very small holding through a VCT).
Best regards

SBP

[totaleclipse] 15/9/2014 11:48

DLKU- a bit harsh I think. The business is making steady progress but it certainly isn't exciting. Exposure to exchange rate shifts is a worry and the only good thing to say about the Selah acquisition is the management aren't going to do anymore dodgy acquisitions in the immediate future until they prove in figures the value of the Selah buy. My view is that the main downward pressure on the price is those acquirees who have passed their lock in period and want cash instead of bits of ever diminishing paper. It'll be interesting to see what additional gems of information are offered at the investor briefing- I have to say I am glad I don't have to stand up and talk about the recent results. They had better keep the positive news flow coming during the second half or I can see 18 pence looming.

[totaleclipse] 15/9/2014 10:10

The management need to do something to stimulate positive comment in the penny tip sheets and main stream press to get this share moving again. My suspicion is they are not worried about the small investors like you and me but the bigger institutional investors and their briefings probably occur over a 5 course meal somewhere. There is an update presentation coming soon but, if last time is anything to go by, the detail does not get published. Updates twice a year and the occasional purchase by directors are not enough to keep the momentum behind this tiddler going- sadly. But at least we know that there bonus share options will not kick in until the price hits mid 40's again. The minute they (the directors) start awarding themselves share options at lower target values then I will ditch them like a stone.

[cisk] 15/9/2014 09:21

can this dog go any lower? wish I sold ages ago...

[totaleclipse] 25/8/2014 09:33

Anyone going to the investor briefing that's coming up who would post the main points on here?